论文部分内容阅读
目的分析静注人免疫球蛋白对于重症手足口病患者的临床疗效。方法将2011年5月至2012年6月期间本院收治的68例重症手足口病患儿分为治疗组和对照组,两组均给予抗病毒药物以及抗生素等基础治疗,治疗组在此基础上加用人免疫球蛋白静脉注射。观察并对比两组患者疗效及不良反应。结果治疗组各典型症状消失时间均显著短于对照组,两组患者均未出现明显不良反应,随访未见复发病例。结论重症手足口病患者早期给予静注入免疫球蛋白治疗,疗效显著,安全有效,值得推广。
Objective To analyze the clinical effect of intravenous immunoglobulin on patients with severe hand-foot-mouth disease. Methods From May 2011 to June 2012, 68 children with severe HFMD admitted to our hospital were divided into treatment group and control group. Both groups were given basic treatment with antiviral drugs and antibiotics. The treatment group was based on this On the increase of human immunoglobulin intravenous injection. Observed and compared two groups of patients efficacy and adverse reactions. Results The disappearance time of each typical symptom in the treatment group was significantly shorter than that in the control group. No obvious adverse reactions were found in both groups, and no recurrence was observed at the follow-up. Conclusion Severe HFMD patients given intravenous immunoglobulin early treatment, the effect is significant, safe and effective, it is worth promoting.